Work

CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis

Year: 2021

Type: article

Source: Multiple Sclerosis and Related Disorders

DOI: 10.1016/j.msard.2021.103448

Authors: David Baker, Amy MacDougall, Angray S. Kang, Klaus Schmierer, Gavin Giovannoni, Ruth Dobson

Institutions: Queen Mary University of London, Blizard Institute, London School of Hygiene & Tropical Medicine, Barts Health NHS Trust, Royal London Hospital

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Merck, Roche, Sanofi, Barts Charity

Award: G7414070065

OpenAlex ID: W4226028004

FWCI: 3.663

Cites: 52

Cited by: 30

Related to: 10